Contineum Therapeutics (CTNM) Other Gross PP&E Adjustments (2023 - 2025)
Contineum Therapeutics (CTNM) has 3 years of Other Gross PP&E Adjustments data on record, last reported at -$4.8 million in Q3 2025.
- For Q3 2025, Other Gross PP&E Adjustments fell 2354.82% year-over-year to -$4.8 million; the TTM value through Sep 2025 reached -$4.8 million, down 2354.82%, while the annual FY2024 figure was -$3.9 million, 744.85% down from the prior year.
- Other Gross PP&E Adjustments reached -$4.8 million in Q3 2025 per CTNM's latest filing, up from -$5.2 million in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at $602000.0 in Q4 2023 and bottomed at -$5.4 million in Q1 2025.
- Average Other Gross PP&E Adjustments over 3 years is -$2.7 million, with a median of -$3.3 million recorded in 2024.
- The widest YoY moves for Other Gross PP&E Adjustments: up 91.79% in 2025, down 2354.82% in 2025.
- A 3-year view of Other Gross PP&E Adjustments shows it stood at $602000.0 in 2023, then tumbled by 744.85% to -$3.9 million in 2024, then fell by 24.57% to -$4.8 million in 2025.
- Per Business Quant database, its latest 3 readings for Other Gross PP&E Adjustments were -$4.8 million in Q3 2025, -$5.2 million in Q2 2025, and -$5.4 million in Q1 2025.